Elevated SARS-CoV-2 in peripheral blood and increased COVID-19 severity in American Indians/Alaska Natives. Issue 14 (July 2022)

• Record Type: Journal Article
• Authors: Perkins, Douglas J; Yingling, Alexandra V; Cheng, Qiuying; Castillo, Amber; Martinez, Janae; Bradfute, Steven B; Leng, Shuguang; Edwards, Jeremy; Guo, Yan; Mertz, Gregory; Harkins, Michelle; Unruh, Mark; Worsham, Anthony; Lambert, Christophe G; Teixeira, J Pedro; Seidenberg, Phillip; Langsjoen, Jens; Schneider, Kristan; Hurwitz, Ivy
• Is Part Of: Experimental biology and medicine. Volume 247:Issue 14(2022)
• Page Start: 1253
• Page End: 1263
• Publication Date: 2022-07
• Subjects: SARS-CoV-2 -- COVID-19 -- race/ethnicity -- viral load -- hospitalization -- intensive care; Physiology -- Periodicals; Biology, Experimental -- Periodicals; Medicine, Experimental -- Periodicals; 610.72
• DOI: 10.1177/15353702221091180
• Languages: English
• ISSNs: 1535-3702

Abstract

Epidemiological data across the United States show health disparities in COVID-19 infection, hospitalization, and mortality by race/ethnicity. While the association between elevated SARS-CoV-2 viral loads (VLs) (i.e. upper respiratory tract (URT) and peripheral blood (PB)) and increased COVID-19 severity has been reported, data remain largely unavailable for some disproportionately impacted racial/ethnic groups, particularly for American Indian or Alaska Native (AI/AN) populations. As such, we determined the relationship between SARS-CoV-2 VL dynamics and disease severity in a diverse cohort of hospitalized patients. Results presented here are for study participants ( n = 94, ages 21–88 years) enrolled in a prospective observational study between May and October 2020 who had SARS-CoV-2 viral clades 20A, C, and G. Based on self-reported race/ethnicity and sample size distribution, the cohort was stratified into two groups: (AI/AN, n = 43) and all other races/ethnicities combined (non-AI/AN, n = 51). SARS-CoV-2 VLs were quantified in the URT and PB on days 0–3, 6, 9, and 14. The strongest predictor of severe COVID-19 in the study population was the mean VL in PB (OR = 3.34; P = 2.00 × 10 −4 ). The AI/AN group had the following: (1) comparable co-morbidities and admission laboratory values, yet more severe COVID-19 (OR = 4.81; P = 0.014); (2) a 2.1 longer duration of hospital stay ( P = 0.023); and (3) higher initial and cumulative PB VLs during severe disease ( P = 0.025). Moreover, self-reported race/ethnicity as AI/AN was the strongest predictor of elevated PB VLs ( β = 1.08; P = 6.00 × 10 −4 ) and detection of SARS-CoV-2 in PB (hazard ratio = 3.58; P = 0.004). The findings presented here suggest a strong relationship between PB VL (magnitude and frequency) and severe COVID-19, particularly for the AI/AN group.